<div id="readability-page-1"><div>TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick &amp; Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick &amp; Foti, LLC (“KSF”) are investigating the proposed merger of Titan Pharmaceuticals, Inc. (the “Company”) (NasdaqCM: TTNP) and KE Sdn. Bhd. Under the terms of the proposed transaction, shareholders of Titan are expected to own approximately 13.3% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to the Company’s shareholders. If you would like to discuss your legal rights regarding the proposed transaction, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-ttnp/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. Kahn Swick &amp; Foti, LLC 1100 Poydras St., Suite 960 New Orleans, LA 70163 CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn <img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNTA4MDU1MzcwODRyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNTA4MDU1MzcwODRyMQ"/> Lewis S. Kahn lewis.kahn@ksfcounsel.com 855-768-1857 View source version on businesswire.com: https://www.businesswire.com/news/home/20250805537084/en/</div></div>

Titan制药

Kahn Swick & Foti, LLC，由前路易斯安那州检察长 Charles C. Foti, Jr.领导，正在调查 Titan Pharmaceuticals, Inc.（TTNP）与 KE Sdn. Bhd.之间的拟议合并。Titan 的股东预计将拥有合并实体约 13.3% 的股份。该公司旨在评估合并过程对 Titan 股东的公平性和充分性。感兴趣的各方可以联系 KSF 以获取有关与该交易相关的法律权利的更多信息

TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

路易斯安那州前总检察长发布 Titan 制药投资者警报：Kahn Swick & Foti, LLC 正在调查 Titan 制药公司（TTNP）的合并事宜